Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops...
Leadership
Faheem HasnainFounder
Co-Founder, CEO, President & Chairman
Bryan Giraudo
COO & CFO
Robert Paul Smith Jr.
Chief Commercial Officer
Christian Waage J.D.
Executive VP, General Counsel & Secretary
Jeanine Anthony
Senior Vice President of Marketing
Deanna Weber
Executive Vice President of Human Resources
Robert F. Roscigno Ph.D.
Senior Vice President of Clinical Development of Pulmonary Vascular Disease
